| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15,000 | $87,900 | $5.86 | 24 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | 24 Jun 2025 | 1 | $0 | 4 | Director | 25 Jun 2025, 17:30 |
| GANX | Gain Therapeutics, Inc. | 24 Jun 2024 | 1 | $0 | 4 | Director | 26 Jun 2024, 21:30 |
| GANX | Gain Therapeutics, Inc. | 28 Mar 2024 | 1 | $115,770 | 4 | Director | 01 Apr 2024, 16:01 |
| GANX | Gain Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:39 |
| GANX | Gain Therapeutics, Inc. | 20 Sep 2022 | 1 | $0 | 4 | Director | 22 Sep 2022, 16:11 |